Ten people to get NHS bionic eyes

« Back to Industry News

22/12/2016

The NHS will pay for 10 blind patients to have "bionic eyes" to help treat an inherited form of blindness. The bionic eye is a retinal implant which interprets images captured by a miniature video camera worn on a pair of glasses.

Five patients will be treated at Manchester Royal Eye Hospital and five at Moorfields Eye Hospital in 2017.

They will be monitored for a year afterwards to see how they get on in everyday life.

"I'm delighted," said Prof Paulo Stanga from the Manchester hospital. He has been involved in earlier trials of the Argus II Bionic Eye, made by the company Second Sight, in retinitis pigmentosa. He added: "It surpassed all of our expectations when we realised that one of the retinitis pigmentosa patients using the bionic eye could identify large letters for the first time in his adult life." This disease, which is often passed down through families, destroys the light-sensing cells in the retina. It leads to vision loss and eventually blindness.

The bionic eye implant receives its visual information from a miniature camera mounted on glasses worn by the patient. The images are converted into electrical pulses and transmitted wirelessly to an array of electrodes attached to the retina. The electrodes stimulate the remaining retina's remaining cells which send the information to the brain.

Gregoire Cosendai, from Second Sight, says: "This is the first time in history that any treatment for this type of blindness has existed and now it is to be offered free of charge to blind patients.
"This is a major victory for blind people in the UK who have supported us in our six-year mission to fund Argus II in England."

Dr Jonathan Fielden, from NHS England, said: "This highly innovative NHS-funded procedure shows real promise and could change lives. "The NHS has given the world medical innovations ranging from modern cataract surgery, new vaccines and hip replacements, now once again the NHS is at the forefront of harnessing ground-breaking science for the benefit of patients in this country."


Click here to view the full related article.

« Back to Industry News